Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Janet Oblinger
Preclinical Validation of AR42, a Novel Histone Deacetylase Inhibitor, as Treatment for Vestibular Schwannomas
Laryngoscope
Otorhinolaryngology
Related publications
Activity of PXD101, a Histone Deacetylase Inhibitor, in Preclinical Ovarian Cancer Studies
Molecular Cancer Therapeutics
Cancer Research
Oncology
Preclinical Anti-Arthritic Study and Pharmacokinetic Properties of a Potent Histone Deacetylase Inhibitor MPT0G009
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Combining PCI-24781, a Novel Histone Deacetylase Inhibitor, With Chemotherapy for the Treatment of Soft Tissue Sarcoma
Clinical Cancer Research
Cancer Research
Oncology
Correction: Combining PCI-24781, a Novel Histone Deacetylase Inhibitor, With Chemotherapy for the Treatment of Soft Tissue Sarcoma
Clinical Cancer Research
Cancer Research
Oncology
Vestibular Schwannomas
Chettinad Health City Medical Journal
Epigenetic Modulation With Oral Histone Deacetylase (HDAC) Inhibitor as a New Treatment Option in JIA
Pediatric Rheumatology
Immunology
Pediatrics
Rheumatology
Allergy
Perinatology
Child Health
Preclinical Studies on Histone Deacetylase Inhibitors as Therapeutic Reagents for Endometrial and Ovarian Cancers
Future Oncology
Medicine
Cancer Research
Oncology
A Novel Histone Deacetylase Inhibitor, CKD5, Has Potent Anti-Cancer Effects in Glioblastoma
Oncotarget
Oncology
Gamma Knife Radiosurgery for Treatment of Growing Vestibular Schwannomas in Patients With Neurofibromatosis Type 2: A Matched Cohort Study With Sporadic Vestibular Schwannomas
Journal of Neurosurgery
Surgery
Neurology
